Skip to main content
Premium Trial:

Request an Annual Quote

Citing Economic Uncertainty, Bruker Sheds 10 Percent of Workforce in US, Germany

Click here for an updated version of this story.

 

NEW YORK, July 8 - Bruker Daltonics said today that "on-going uncertain economic conditions" has forced it to lay off roughly 10 percent of its workforce in the United States and Germany.

 

"As demand in several customer segments is experiencing slower growth, we are taking decisive action to reduce our cost structure," said Frank Laukien, president and CEO. "Once fully implemented, we expect cost savings of about $2.5 million next year."

Calling the move "aggressive," Bruker said the lay offs come at a time when the company faces slowed bookings among pharma, biotech, and chemical customers. Bruker, which posted 22-percent growth in second-quarter year-over-year bookings, also blamed the decrease on the departure of distributor companies like Variagenics and Perkin-Elmer.

 

However, Bruker said booking have grown among universities, medical schools, governments, and nonprofit groups, and the company said it expects "strategic sales" to grow for the rest of the year through Agilent and Sequenom.

"Fundamentally, our life-science research and pharma/biotech markets have healthy long-term trends, and we see strong funding for our life-science systems based on mass spectrometry, due to their enabling role in critical fields like genotyping, proteomics and metabolomics," said Laukien.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.